The US Food and Drug Administration (FDA) has warned consumers and retailers not to “eat, sell, or serve” any of Diamond Shruumz-brand’s micro-dosing chocolate bars, infused cones, and microdose and macro dose gummies. This warning follows reports of hospitalizations across eight states linked to the consumption of these products.

Illness reports and Symptoms

The FDA advisory highlighted that twelve individuals have reported falling ill after consuming Diamond Shruumz products. The cases are distributed across several states:

– Arizona: 4 cases

– Indiana: 2 cases

– Alabama: 1 case

– Missouri: 1 case

– Kentucky: 1 case

– Nevada: 1 case

– Pennsylvania: 1 case

– South Carolina: 1 case

Out of these twelve cases, ten individuals have been hospitalized. The reported symptoms include:

• Seizures
• Central nervous system depression (loss of consciousness, confusion, sleepiness)
• Agitation
• Abnormal heart rates
• Hyper and hypotension
• Nausea and vomiting

No deaths have been reported in connection with the consumption of these products.

Product Details and Company Response

Microdosing involves taking small amounts of psychedelic substances, which some users claim can enhance mood and concentration. According to Diamond Shruumz’s website, their products contain a “proprietary blend of nootropic and functional mushrooms” and do not include psilocybin, amanita, or any scheduled drugs. Despite these claims, the exact cause of the illnesses is under investigation.

The FDA is investigating in collaboration with the US Centers for Disease Control and Prevention (CDC), America’s Poison Centers, and state and local partners. CNN has reached out to Diamond Shruumz for comments but has not yet received a response

The FDA advises individuals who may have consumed Diamond Shruumz’s products and experience adverse effects to seek medical attention promptly. Additionally, contacting the Poison Help Line at 1-800-222-1222 is recommended for further assistance.

The FDA’s warning highlights the potential risks associated with the consumption of certain microdosing products, even those that claim to be free of traditional psychedelic substances. Consumers are urged to be vigilant and report any adverse effects to healthcare providers or relevant authorities.